首页 > 最新文献

Acta Cytologica最新文献

英文 中文
p53 and vimentin double immunostaining to differentiate between high-grade urothelial carcinoma cells and benign atypical cells 用 p53 和波形蛋白双重免疫染色法区分高级别尿路上皮癌细胞和良性非典型细胞
Pub Date : 2024-05-21 DOI: 10.1159/000539417
Hiroko Ose, Akihiro Nakamura, T. Nukaya, T. Sofue, Reiji Haba, Tomoo Itoh, Shingo Kamoshida, Hiroyuki Ohsaki
Introduction: Urine cytology is an indispensable test for detecting high-grade urothelial carcinoma (HGUC); however, the distinction between HGUC cells and morphologically similar benign atypical cells poses clinical challenges. In this study, we performed double immunostaining for p53 and vimentin to establish a diagnostic method to accurately distinguish HGUC cells from benign atypical cells.Methods: This study included 41 cases of HGUC, 11 of urolithiasis, and 22 of glomerular disease diagnosed histopathologically or clinically. After preparing urine cytology specimens from voided urine samples, p53 immunostaining was performed, and the p53 positive intensity and p53 positivity rate were calculated. Subsequently, vimentin immunostaining was performed on the same specimens to calculate the rate of vimentin positivity.Results: The HGUC cell group had a mean p53 positive intensity of 2.40, a mean p53 positivity rate of 73.2%, and a mean vimentin positivity rate of 5.1%. In contrast, the mean p53 positive intensity, p53 positivity rate, and vimentin-positivity rate was 1.63, 36.7%, and 66.2%, respectively, in the benign atypical cell group. There were significant differences between the two groups for each parameter. Moreover, two multiple logistic regression models combining the results of these three parameters exhibited higher sensitivity and specificity than solely assessing the p53 positive intensity, positivity rate, and vimentin positivity rate.Conclusion: Since double immunostaining with p53 and vimentin distinguishes HGUC cells from benign atypical cells, it could be used to improve the diagnostic accuracy of urine cytology.
导言:尿液细胞学检查是检测高级别尿路上皮癌(HGUC)不可或缺的检查方法;然而,如何区分HGUC细胞和形态相似的良性非典型细胞给临床带来了挑战。在本研究中,我们对 p53 和波形蛋白进行了双重免疫染色,以建立一种能准确区分 HGUC 细胞和良性非典型细胞的诊断方法:本研究包括41例经组织病理学或临床诊断的HGUC、11例尿路结石和22例肾小球疾病。从排空的尿液样本中制备尿液细胞学标本后,进行 p53 免疫染色,并计算 p53 阳性强度和 p53 阳性率。随后,对同一标本进行波形蛋白免疫染色,计算波形蛋白阳性率:结果:HGUC细胞组的平均p53阳性强度为2.40,平均p53阳性率为73.2%,平均波形蛋白阳性率为5.1%。相比之下,良性非典型细胞组的平均 p53 阳性强度、p53 阳性率和波形蛋白阳性率分别为 1.63%、36.7% 和 66.2%。两组在各项参数上均存在明显差异。此外,与单纯评估 p53 阳性强度、阳性率和波形蛋白阳性率相比,结合这三个参数结果的两个多重逻辑回归模型显示出更高的灵敏度和特异性:结论:p53 和波形蛋白双重免疫染色可将 HGUC 细胞与良性非典型细胞区分开来,因此可用于提高尿液细胞学诊断的准确性。
{"title":"p53 and vimentin double immunostaining to differentiate between high-grade urothelial carcinoma cells and benign atypical cells","authors":"Hiroko Ose, Akihiro Nakamura, T. Nukaya, T. Sofue, Reiji Haba, Tomoo Itoh, Shingo Kamoshida, Hiroyuki Ohsaki","doi":"10.1159/000539417","DOIUrl":"https://doi.org/10.1159/000539417","url":null,"abstract":"Introduction: Urine cytology is an indispensable test for detecting high-grade urothelial carcinoma (HGUC); however, the distinction between HGUC cells and morphologically similar benign atypical cells poses clinical challenges. In this study, we performed double immunostaining for p53 and vimentin to establish a diagnostic method to accurately distinguish HGUC cells from benign atypical cells.\u0000Methods: This study included 41 cases of HGUC, 11 of urolithiasis, and 22 of glomerular disease diagnosed histopathologically or clinically. After preparing urine cytology specimens from voided urine samples, p53 immunostaining was performed, and the p53 positive intensity and p53 positivity rate were calculated. Subsequently, vimentin immunostaining was performed on the same specimens to calculate the rate of vimentin positivity.\u0000Results: The HGUC cell group had a mean p53 positive intensity of 2.40, a mean p53 positivity rate of 73.2%, and a mean vimentin positivity rate of 5.1%. In contrast, the mean p53 positive intensity, p53 positivity rate, and vimentin-positivity rate was 1.63, 36.7%, and 66.2%, respectively, in the benign atypical cell group. There were significant differences between the two groups for each parameter. Moreover, two multiple logistic regression models combining the results of these three parameters exhibited higher sensitivity and specificity than solely assessing the p53 positive intensity, positivity rate, and vimentin positivity rate.\u0000Conclusion: Since double immunostaining with p53 and vimentin distinguishes HGUC cells from benign atypical cells, it could be used to improve the diagnostic accuracy of urine cytology.\u0000","PeriodicalId":502148,"journal":{"name":"Acta Cytologica","volume":"36 22","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141113480","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Acta Cytologica
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1